(Treffer aus TechnoPharm, Nr. 02, Seite 123 (2012))
Arceneaux D | Hübschmann M
Robot System Safety in Aseptic Drug Manufacturing / Arceneaux und Hübschmann • Robot System Safety · Arceneaux D, Hübschmann M · Stäubli Corporation, Duncan, USA und Stäubli Tec-Systems GmbH Robotics, Bayreuth
Industrial manufacturing of injectable drug products presents distinct challenges centering on minimizing contamination, thus to ensure patient and personnel safety as well as product quality. In order to meet these challenges, pharmaceutical companies are increasingly implementing Advanced Aseptic Processing (AAP) systems. These utilize advanced automation, Restricted Access Barrier Systems (RABS), isolator-barrier systems and robotics, with the goal of restricting operator access to the product and to critical areas of manufacturing machinery. An isolator-based robot system, properly implemented according to ANSI/RIA R15.06 safety requirements for industrial robots and robot systems and current Good Manufacturing Practices (GMPs), results in a robot cell ...